Influence of synthetic somatostatin upon growth hormone release from perifused rat pituitaries

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Basal release of pre-labeled, stored tritiated rat growth hormone ([3H]rGH) from perifused rat pituitary explants is a constant fraction of pituitary [3H]rGH content. Synthetic somatostatin (SRIF) inhibits the release of pre-labeled, stored [3H]rGH in a dose-dependent fashion. Prolonged exposure to SRIF results in an immediate and continuous inhibition of [3H]rGH release. In the in vitro perifusion system, the maximal inhibition, which is achieved with 25 nM SRIF, results in a rate of [3H]rGH release which is 30 to 40 per cent of basal release. Pulses of SRIF produce inhibition of [3H]rGH release followed by rebound release after withdrawal of SRIF. When the time of exposure to SRIF is held constant, both the SRIF-induced inhibition and the rebound release of [3H]rGH are dose-dependent. A similar progressive response is seen when a constant SRIF concentration is pulsed for variable periods of time. There is no net inhibition of [3H]rGH release by pulses of SRIF.

Original languageEnglish (US)
Pages (from-to)678-683
Number of pages6
JournalEndocrinology
Volume99
Issue number3
DOIs
StatePublished - Jan 1 1976

Fingerprint

Somatostatin
Growth Hormone
In Vitro Techniques

ASJC Scopus subject areas

  • Endocrinology

Cite this

Influence of synthetic somatostatin upon growth hormone release from perifused rat pituitaries. / Stachura, M. E.

In: Endocrinology, Vol. 99, No. 3, 01.01.1976, p. 678-683.

Research output: Contribution to journalArticle

@article{3f1e810ccd764a51926f73189b2a5c2b,
title = "Influence of synthetic somatostatin upon growth hormone release from perifused rat pituitaries",
abstract = "Basal release of pre-labeled, stored tritiated rat growth hormone ([3H]rGH) from perifused rat pituitary explants is a constant fraction of pituitary [3H]rGH content. Synthetic somatostatin (SRIF) inhibits the release of pre-labeled, stored [3H]rGH in a dose-dependent fashion. Prolonged exposure to SRIF results in an immediate and continuous inhibition of [3H]rGH release. In the in vitro perifusion system, the maximal inhibition, which is achieved with 25 nM SRIF, results in a rate of [3H]rGH release which is 30 to 40 per cent of basal release. Pulses of SRIF produce inhibition of [3H]rGH release followed by rebound release after withdrawal of SRIF. When the time of exposure to SRIF is held constant, both the SRIF-induced inhibition and the rebound release of [3H]rGH are dose-dependent. A similar progressive response is seen when a constant SRIF concentration is pulsed for variable periods of time. There is no net inhibition of [3H]rGH release by pulses of SRIF.",
author = "Stachura, {M. E.}",
year = "1976",
month = "1",
day = "1",
doi = "10.1210/endo-99-3-678",
language = "English (US)",
volume = "99",
pages = "678--683",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Influence of synthetic somatostatin upon growth hormone release from perifused rat pituitaries

AU - Stachura, M. E.

PY - 1976/1/1

Y1 - 1976/1/1

N2 - Basal release of pre-labeled, stored tritiated rat growth hormone ([3H]rGH) from perifused rat pituitary explants is a constant fraction of pituitary [3H]rGH content. Synthetic somatostatin (SRIF) inhibits the release of pre-labeled, stored [3H]rGH in a dose-dependent fashion. Prolonged exposure to SRIF results in an immediate and continuous inhibition of [3H]rGH release. In the in vitro perifusion system, the maximal inhibition, which is achieved with 25 nM SRIF, results in a rate of [3H]rGH release which is 30 to 40 per cent of basal release. Pulses of SRIF produce inhibition of [3H]rGH release followed by rebound release after withdrawal of SRIF. When the time of exposure to SRIF is held constant, both the SRIF-induced inhibition and the rebound release of [3H]rGH are dose-dependent. A similar progressive response is seen when a constant SRIF concentration is pulsed for variable periods of time. There is no net inhibition of [3H]rGH release by pulses of SRIF.

AB - Basal release of pre-labeled, stored tritiated rat growth hormone ([3H]rGH) from perifused rat pituitary explants is a constant fraction of pituitary [3H]rGH content. Synthetic somatostatin (SRIF) inhibits the release of pre-labeled, stored [3H]rGH in a dose-dependent fashion. Prolonged exposure to SRIF results in an immediate and continuous inhibition of [3H]rGH release. In the in vitro perifusion system, the maximal inhibition, which is achieved with 25 nM SRIF, results in a rate of [3H]rGH release which is 30 to 40 per cent of basal release. Pulses of SRIF produce inhibition of [3H]rGH release followed by rebound release after withdrawal of SRIF. When the time of exposure to SRIF is held constant, both the SRIF-induced inhibition and the rebound release of [3H]rGH are dose-dependent. A similar progressive response is seen when a constant SRIF concentration is pulsed for variable periods of time. There is no net inhibition of [3H]rGH release by pulses of SRIF.

UR - http://www.scopus.com/inward/record.url?scp=0017185843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017185843&partnerID=8YFLogxK

U2 - 10.1210/endo-99-3-678

DO - 10.1210/endo-99-3-678

M3 - Article

C2 - 954664

AN - SCOPUS:0017185843

VL - 99

SP - 678

EP - 683

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 3

ER -